Page last updated: 2024-08-25

rosiglitazone and Cell Transformation, Neoplastic

rosiglitazone has been researched along with Cell Transformation, Neoplastic in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (62.50)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrisani, OM; Bi, P; Bidwell, CA; Castro, B; Durkes, A; Elzey, BD; Freeman, JL; Karki, A; Konieczny, SF; Kuang, S; Wang, C; Wirbisky, SE; Yue, F	1
Bojkova, B; Garajova, M; Kajo, K; Kassayova, M; Kiskova, T; Korpova, M; Kubatka, P; Miklosova, M; Orendas, P; Pec, M	1
Knight, BB; Nagalingam, A; Oberlick, E; Saxena, NK; Sharma, D; Taliaferro-Smith, L	1
Herbert, BS; Hynan, LS; Kopelovich, L; LaRue, DM; Pearce, VP; Shay, JW; Wright, WE	1
Fischer, SM; He, G; Lubet, RA; Muga, S; Thuillier, P	1
Araki, O; Cheng, SY; Furuya, F; Kato, Y; Willingham, MC; Ying, H; Zhao, L	1
Clark, OH; Duh, QY; Greenspan, FS; Kebebew, E; Lindsay, S; Morita, E; Peng, M; Reiff, E; Treseler, P; Woeber, KA	1
DuBois, RN; Shao, J; Sheng, H	1

Trials

1 trial(s) available for rosiglitazone and Cell Transformation, Neoplastic

Article	Year
A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer. Surgery, 2006, Volume: 140, Issue:6 Topics: Adult; Aged; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Male; Middle Aged; PPAR gamma; Radionuclide Imaging; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms	2006

Article

Year

A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer.

Surgery, 2006, Volume: 140, Issue:6

Topics: Adult; Aged; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Male; Middle Aged; PPAR gamma; Radionuclide Imaging; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms

2006

Other Studies

7 other study(ies) available for rosiglitazone and Cell Transformation, Neoplastic

Article	Year
Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice. The Journal of experimental medicine, 2016, 09-19, Volume: 213, Issue:10 Topics: Adipocytes; Animals; Biomarkers, Tumor; Cell Dedifferentiation; Cell Differentiation; Cell Lineage; Cell Proliferation; Cell Transformation, Neoplastic; Diabetes Mellitus, Experimental; Diamines; Dibenzazepines; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Ligands; Lipid Metabolism; Liposarcoma; Metabolic Syndrome; Mice, Inbred C57BL; PPAR gamma; Precancerous Conditions; PTEN Phosphohydrolase; Receptors, Notch; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Xenograft Model Antitumor Assays	2016
Rosiglitazone shows partial oncostatic effect in rat mammary carcinogenesis. Neoplasma, 2013, Volume: 60, Issue:1 Topics: Animals; Carcinogens; Cell Transformation, Neoplastic; Female; Glycemic Index; Hypoglycemic Agents; Insulin; Mammary Neoplasms, Animal; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones	2013
Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis. Neoplasia (New York, N.Y.), 2013, Volume: 15, Issue:1 Topics: Adiponectin; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Leptin; MCF-7 Cells; Mice; Mice, Nude; Neoplasm Invasiveness; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins c-akt; Rosiglitazone; Signal Transduction; Thiazolidinediones	2013
A peroxisome proliferator-activated receptor-gamma agonist and the p53 rescue drug CP-31398 inhibit the spontaneous immortalization of breast epithelial cells. Cancer research, 2003, Apr-15, Volume: 63, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Breast; Cell Transformation, Neoplastic; DNA Damage; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Li-Fraumeni Syndrome; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Telomere; Thiazoles; Thiazolidinediones; Transcription Factors	2003
The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin. Molecular carcinogenesis, 2005, Volume: 43, Issue:4 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Proliferation; Cell Transformation, Neoplastic; Chromans; Diet; Female; Keratinocytes; Ligands; Mice; PPAR gamma; RNA, Messenger; Rosiglitazone; Skin Neoplasms; Tetradecanoylphorbol Acetate; Thiazolidinediones; Troglitazone; Ultraviolet Rays	2005
PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway. Oncogene, 2006, May-04, Volume: 25, Issue:19 Topics: Animals; Apoptosis; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin D1; Female; Humans; Male; Mice; Mice, Mutant Strains; NF-kappa B; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones; Thyroid Hormone Receptors beta; Thyroid Neoplasms	2006
Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells. Cancer research, 2002, Jun-01, Volume: 62, Issue:11 Topics: Animals; Cell Division; Cell Transformation, Neoplastic; Cyclooxygenase 2; Enzyme Induction; Epoprostenol; Genes, ras; Intestinal Mucosa; Intestines; Isoenzymes; Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Protein Isoforms; ras Proteins; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Transcription Factors	2002